|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y,
Ni Y, Zhao A, Xu LX, Cai S, et al: Serum metabolite profiling of
human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome
Res. 8:4844–4850. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miller KD, Nogueira L, Mariotto AB,
Rowland JH, Yabroff KR, Alfano CM, Jemal A, Kramer JL and Siegel
RL: Cancer treatment and survivorship statistics, 2019. CA Cancer J
Clin. 69:363–385. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang J, Yan F, Zhao Q, Zhan F, Wang R,
Wang L, Zhang Y and Huang X: Circulating exosomal miR-125a-3p as a
novel biomarker for early-stage colon cancer. Sci Rep. 7:41502017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiménez B, Mirnezami R, Kinross J, Cloarec
O, Keun HC, Holmes E, Goldin RD, Ziprin P, Darzi A and Nicholson
JK: 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic
‘field-effects’ enables colorectal cancer staging and
prognostication. J Proteome Res. 12:959–968. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kotronoulas G, Papadopoulou C,
Burns-Cunningham K, Simpson M and Maguire R: A systematic review of
the supportive care needs of people living with and beyond cancer
of the colon and/or rectum. Eur J Oncol Nurs. 29:60–70. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pignone M and Levin B: Recent developments
in colorectal cancer screening and prevention. Am Fam Physician.
66:297–302. 2002.PubMed/NCBI
|
|
8
|
Kronborg O: Colon polyps and cancer.
Endoscopy. 36:3–7. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pellino G, Simillis C, Kontovounisios C,
Baird DL, Nikolaou S, Warren O, Tekkis PP and Rasheed S: Colorectal
cancer diagnosed during pregnancy: Systematic review and treatment
pathways. Eur J Gastroenterol Hepatol. 29:743–753. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Seeber A and Gastl G: Targeted Therapy of
Colorectal Cancer. Oncol Res Treat. 39:796–802. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pohl M and Schmiegel W: Therapeutic
Strategies in Diseases of the Digestive Tract - 2015 and Beyond
Targeted Therapies in Colon Cancer Today and Tomorrow. Dig Dis.
34:574–579. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Courant F, Antignac JP, Monteau F and Le
Bizec B: Metabolomics as a potential new approach for investigating
human reproductive disorders. J Proteome Res. 12:2914–2920. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Manna SK, Krausz KW, Bonzo JA, Idle JR and
Gonzalez FJ: Metabolomics reveals aging-associated attenuation of
noninvasive radiation biomarkers in mice: Potential role of
polyamine catabolism and incoherent DNA damage-repair. J Proteome
Res. 12:2269–2281. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang X, Yang B, Sun H and Zhang A: Pattern
recognition approaches and computational systems tools for ultra
performance liquid chromatography-mass spectrometry-based
comprehensive metabolomic profiling and pathways analysis of
biological data sets. Anal Chem. 84:428–439. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang A, Sun H, Wang P, Han Y and Wang X:
Modern analytical techniques in metabolomics analysis. Analyst
(Lond). 137:293–300. 2012. View Article : Google Scholar
|
|
16
|
Mondul AM, Moore SC, Weinstein SJ,
Männistö S, Sampson JN and Albanes D: 1-stearoylglycerol is
associated with risk of prostate cancer: Results from serum
metabolomic profiling. Metabolomics. 10:1036–1041. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Aboud OA and Weiss RH: New opportunities
from the cancer metabolome. Clin Chem. 59:138–146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ritchie SA, Ahiahonu PWK, Jayasinghe D,
Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, et
al: Reduced levels of hydroxylated, polyunsaturated ultra
long-chain fatty acids in the serum of colorectal cancer patients:
Implications for early screening and detection. BMC Med. 8:132010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Long Y, Sanchez-Espiridion B, Lin M, White
L, Mishra L, Raju GS, Kopetz S, Eng C, Hildebrandt MAT, Chang DW,
et al: Global and targeted serum metabolic profiling of colorectal
cancer progression. Cancer. 123:4066–4074. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deng L, Gu H, Zhu J, Nagana Gowda GA,
Djukovic D, Chiorean EG and Raftery D: Combining NMR and LC/MS
using backward variable elimination: Metabolomics analysis of
colorectal cancer, polyps, and healthy controls. Anal Chem.
88:7975–7983. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu J, Djukovic D, Deng L, Gu H, Himmati
F, Abu Zaid M, Chiorean EG and Raftery D: Targeted serum metabolite
profiling and sequential metabolite ratio analysis for colorectal
cancer progression monitoring. Anal Bioanal Chem. 407:7857–7863.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu J, Djukovic D, Deng L, Gu H, Himmati
F, Chiorean EG and Raftery D: Colorectal cancer detection using
targeted serum metabolic profiling. J Proteome Res. 13:4120–4130.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Uchiyama K, Yagi N, Mizushima K,
Higashimura Y, Hirai Y, Okayama T, Yoshida N, Katada K, Kamada K,
Handa O, et al: Serum metabolomics analysis for early detection of
colorectal cancer. J Gastroenterol. 52:677–694. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nishiumi S, Kobayashi T, Kawana S, Unno Y,
Sakai T, Okamoto K, Yamada Y, Sudo K, Yamaji T, Saito Y, et al:
Investigations in the possibility of early detection of colorectal
cancer by gas chromatography/triple-quadrupole mass spectrometry.
Oncotarget. 8:17115–17126. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Singletary SE, Greene FL and Sobin LH:
Classification of isolated tumor cells: Clarification of the 6th
edition of the American Joint Committee on Cancer Staging Manual.
Cancer. 98:2740–2741. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li W, Ye F, Wang D, Sun X, Tong W, Lian G,
Jiang J, Suo J and Zhang DY: Protein predictive signatures for
lymph node metastasis of gastric cancer. Int J Cancer.
132:1851–1859. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang D, Ye F, Sun Y, Li W, Liu H, Jiang J,
Zhang Y, Liu C, Tong W, Gao L, et al: Protein signatures for
classification and prognosis of gastric cancer a signaling
pathway-based approach. Am J Pathol. 179:1657–1666. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheng Y, Xie G, Chen T, Qiu Y, Zou X,
Zheng M, Tan B, Feng B, Dong T, He P, et al: Distinct urinary
metabolic profile of human colorectal cancer. J Proteome Res.
11:1354–1363. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vahabi F, Sadeghi S, Arjmand M, Mirkhani
F, Hosseini E, Mehrabanfar M, Hajhosseini R, Iravani A, Bayat P and
Zamani Z: Staging of colorectal cancer using serum metabolomics
with 1HNMR Spectroscopy. Iran J Basic Med Sci. 20:835–840.
2017.PubMed/NCBI
|
|
30
|
Yang W, Mu T, Jiang J, Sun Q, Hou X, Sun
Y, Zhong L, Wang C and Sun C: Identification of Potential
Biomarkers and Metabolic Profiling of Serum in Ovarian Cancer
Patients Using UPLC/Q-TOF MS. Cell Physiol Biochem. 51:1134–1148.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma Y, Zhang P, Wang F, et al: An
integrated proteomics and metabolome approach for defining
oncofetal biomarkers in the CC. Ann Surg. 255:720–730. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Carloni V, Luong TV and Rombouts K:
Hepatic stellate cells and extracellular matrix in hepatocellular
carcinoma: More complicated than ever. Liver Int. 34:834–843. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bertorelle R, Briarava M, Rampazzo E,
Biasini L, Agostini M, Maretto I, Lonardi S, Friso ML, Mescoli C,
Zagonel V, et al: Telomerase is an independent prognostic marker of
overall survival in patients with colorectal cancer. Br J Cancer.
108:278–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Koga Y, Yamazaki N, Yamamoto Y, Yamamoto
S, Saito N, Kakugawa Y, Otake Y, Matsumoto M and Matsumura Y: Fecal
miR-106a is a useful marker for colorectal cancer patients with
false-negative results in immunochemical fecal occult blood test.
Cancer Epidemiol Biomarkers Prev. 22:1844–1852. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zheng X, Xie G and Jia W: Metabolomic
profiling in colorectal cancer: Opportunities for personalized
medicine. Per Med. 10:741–755. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang H, Tso VK, Slupsky CM and Fedorak RN:
Metabolome and detection of CC in humans: A systematic review.
Future Oncol. 6:1395–1406. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bell SJ: The Effect of Vitamin D3 on
Hepcidin and IL-8 Expression in Monocytes. J Hematol (Brossard).
2:1–7. 2013.
|
|
38
|
Liang CJ, Yen YH, Hung LY, Wang SH, Pu CM,
Chien HF, Tsai JS, Lee CW, Yen FL and Chen YL: Thalidomide inhibits
fibronectin production in TGF-β1-treated normal and keloid
fibroblasts via inhibition of the p38/Smad3 pathway. Biochem
Pharmacol. 85:1594–1602. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hedger MP, Winnall WR, Phillips DJ and de
Kretser DM: The regulation and functions of activin and follistatin
in inflammation and immunity. Vitam Horm. 85:255–297. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xu Q, Tan Y, Zhang K and Li Y: Crosstalk
between p38 and Smad3 through TGF-β1 in JEG-3 choriocarcinoma
cells. Int J Oncol. 43:1187–1193. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kikuta J, Kawamura S, Okiji F, Shirazaki
M, Sakai S, Saito H and Ishii M: Sphingosine-1-phosphate-mediated
osteoclast precursor monocyte migration is a critical point of
control in antibone-resorptive action of active vitamin D. Proc
Natl Acad Sci USA. 110:7009–7013. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang S and Qiu MX: Progress on the
development of relations of Smad4 protein and tumorigenesis. Pract
J Clin Med. 1:158–160,161. 2015.(In Chinese).
|
